Romoxipride en es it fr

Romoxipride Brand names, Romoxipride Analogs

Romoxipride Brand Names Mixture

  • No information avaliable

Romoxipride Chemical_Formula


Romoxipride RX_link

No information avaliable

Romoxipride fda sheet

Romoxipride msds (material safety sheet)

Romoxipride Synthesis Reference

No information avaliable

Romoxipride Molecular Weight

371.269 g/mol

Romoxipride Melting Point

No information avaliable

Romoxipride H2O Solubility

74 mg/L

Romoxipride State


Romoxipride LogP


Romoxipride Dosage Forms


Romoxipride Indication

For the treatment of schizophrenia.

Romoxipride Pharmacology

Remoxipride, a substituted benzamide, is a selective D2 receptor antagonist. It has been shown to be effective in the treatment of schizophrenia. Some antipsychotics block domapinergic receptors as well as cholinergic, noradrenergic and histaminergic receptors. Remoxipride was developed to act specifically on the dopamine D2 receptor. As a consequence, several undesired side effects can occur. Patients often feel they are not taking any antipsychotic drug. It has a potent affinity for the sigma receptor, but it is unclear whether it is a sigma agonist or antagonist. The contribution of this property to its clinical profile is unknown. Blocking the D2 dopamine receptor is known to cause relapse in patients that have achieved remission from depression, and such blocking also counteracts the effectiveness of SSRI medication.

Romoxipride Absorption

Rapidly absorbed. Absolute bioavailability is 90%.

Romoxipride side effects and Toxicity

No information avaliable

Romoxipride Patient Information

No information avaliable

Romoxipride Organisms Affected

Humans and other mammals